162 related articles for article (PubMed ID: 14728937)
1. The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting.
Koedoot CG; Oort FJ; de Haan RJ; Bakker PJ; de Graeff A; de Haes JC
Eur J Cancer; 2004 Jan; 40(2):225-35. PubMed ID: 14728937
[TBL] [Abstract][Full Text] [Related]
2. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients' preferences.
Henselmans I; Van Laarhoven HW; Van der Vloodt J; De Haes HC; Smets EM
Palliat Med; 2017 Jul; 31(7):625-633. PubMed ID: 28618897
[TBL] [Abstract][Full Text] [Related]
3. Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.
Koedoot CG; de Haan RJ; Stiggelbout AM; Stalmeier PF; de Graeff A; Bakker PJ; de Haes JC
Br J Cancer; 2003 Dec; 89(12):2219-26. PubMed ID: 14676798
[TBL] [Abstract][Full Text] [Related]
4. Who should provide care for patients receiving palliative chemotherapy? A qualitative study among Dutch general practitioners and oncologists.
Wind J; Nugteren IC; van Laarhoven HWM; van Weert HCPM; Henselmans I
Scand J Prim Health Care; 2018 Dec; 36(4):437-445. PubMed ID: 30375906
[TBL] [Abstract][Full Text] [Related]
5. Discussing adjuvant cancer therapy.
Leighl N; Gattellari M; Butow P; Brown R; Tattersall MH
J Clin Oncol; 2001 Mar; 19(6):1768-78. PubMed ID: 11251008
[TBL] [Abstract][Full Text] [Related]
6. What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study.
Audrey S; Abel J; Blazeby JM; Falk S; Campbell R
BMJ; 2008 Jul; 337():a752. PubMed ID: 18669570
[TBL] [Abstract][Full Text] [Related]
7. Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.
Koedoot CG; De Haes JC; Heisterkamp SH; Bakker PJ; De Graeff A; De Haan RJ
J Clin Oncol; 2002 Sep; 20(17):3658-64. PubMed ID: 12202667
[TBL] [Abstract][Full Text] [Related]
8. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Honkoop AH; Los M; van der Graaf WT; Stalmeier PF
J Cancer Educ; 2016 Sep; 31(3):443-8. PubMed ID: 25985960
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Patient-Physician Concordance in the Understanding of Chemotherapy Treatment Plans Among Patients With Cancer.
Almalki H; Absi A; Alghamdi A; Alsalmi M; Khan M
JAMA Netw Open; 2020 Mar; 3(3):e200341. PubMed ID: 32125427
[TBL] [Abstract][Full Text] [Related]
10. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.
Siminoff LA; Graham GC; Gordon NH
Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520
[TBL] [Abstract][Full Text] [Related]
11. Who wants second-line, palliative chemotherapy?
Balmer CE; Thomas P; Osborne RJ
Psychooncology; 2001; 10(5):410-8. PubMed ID: 11536419
[TBL] [Abstract][Full Text] [Related]
12. When the treatment goal is not cure: are cancer patients equipped to make informed decisions?
Gattellari M; Voigt KJ; Butow PN; Tattersall MH
J Clin Oncol; 2002 Jan; 20(2):503-13. PubMed ID: 11786580
[TBL] [Abstract][Full Text] [Related]
13. The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study.
Detmar SB; Muller MJ; Wever LD; Schornagel JH; Aaronson NK
JAMA; 2001 Mar; 285(10):1351-7. PubMed ID: 11255393
[TBL] [Abstract][Full Text] [Related]
14. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
[TBL] [Abstract][Full Text] [Related]
15. Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making.
Engelhardt EG; Pieterse AH; van der Hout A; de Haes HJ; Kroep JR; Quarles van Ufford-Mannesse P; Portielje JE; Smets EM; Stiggelbout AM
Eur J Cancer; 2016 Oct; 66():55-66. PubMed ID: 27525573
[TBL] [Abstract][Full Text] [Related]
16. Informed consent and palliative chemotherapy.
Munday DF; Maher EJ
BMJ; 2008 Jul; 337():a868. PubMed ID: 18669571
[No Abstract] [Full Text] [Related]
17. Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy.
Grunfeld EA; Maher EJ; Browne S; Ward P; Young T; Vivat B; Walker G; Wilson C; Potts HW; Westcombe AM; Richards MA; Ramirez AJ
J Clin Oncol; 2006 Mar; 24(7):1090-8. PubMed ID: 16505428
[TBL] [Abstract][Full Text] [Related]
18. Reflections on communication of disease prognosis and life expectancy by patients with colorectal cancer undergoing palliative care: a qualitative study.
Rohde G; Söderhamn U; Vistad I
BMJ Open; 2019 Mar; 9(3):e023463. PubMed ID: 30850402
[TBL] [Abstract][Full Text] [Related]
19. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
[TBL] [Abstract][Full Text] [Related]
20. What are the barriers faced by medical oncologists in initiating discussion of palliative care? A qualitative study in Flanders, Belgium.
Horlait M; Chambaere K; Pardon K; Deliens L; Van Belle S
Support Care Cancer; 2016 Sep; 24(9):3873-81. PubMed ID: 27086311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
